colorectal cancer
Showing NaN - NaN of 111
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Colorectal Cancer Trial in Philadelphia (No Direct Patient Outreach, Direct Patient Outreach: Colonoscopy Only, Direct Patient
Not yet recruiting
- Colorectal Cancer
- No Direct Patient Outreach
- +4 more
-
Philadelphia, PennsylvaniaPenn Medicine
Jan 27, 2023
Colorectal Cancer Screening in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- +2 more
- Stool tests
-
Los Angeles, California
- +24 more
Jan 26, 2023
Colorectal Cancer, Colon Cancer Trial in Philadelphia (Differentiated Box, Standard Mail, Text)
Completed
- Colorectal Cancer
- Colon Cancer
- Differentiated Box
- +5 more
-
Philadelphia, PennsylvaniaPenn Medicine
Jan 27, 2023
Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)
Completed
- Pancreatic Cancer
- +2 more
- AMG820 and pembrolizumab
-
Atlanta, Georgia
- +14 more
Jan 18, 2023
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer
Active, not recruiting
- Colorectal Cancer
- mt-sDNA 2.0 screening test
- +2 more
-
Birmingham, Alabama
- +191 more
Jan 9, 2023
2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA
Active, not recruiting
- Colorectal Cancer
- Blood Sample Collection
-
Birmingham, Alabama
- +189 more
Jan 9, 2023
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Among Racially Diverse Zip Codes inPersistent Poverty County
Not yet recruiting
- Colorectal Cancer
- Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 6, 2022
Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Colorectal Cancer Trial in Philadelphia (Generic message, Tailored message)
Active, not recruiting
- Colorectal Cancer
- Generic message
- Tailored message
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Sep 26, 2022
Colorectal Cancer Trial in United States (Oral Tablet: Cabozantinib)
Completed
- Colorectal Cancer
- Oral Tablet: Cabozantinib
-
Tucson, Arizona
- +9 more
Jun 22, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)
Recruiting
- Colorectal Cancer
- +3 more
- Nivolumab
- +3 more
-
Birmingham, Alabama
- +101 more
Jun 13, 2022
Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +5 more
- DCC-3116
- +3 more
-
Boston, Massachusetts
- +4 more
May 25, 2022
Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,
Recruiting
- Metastatic Uveal Melanoma
- +3 more
- IDE196
- +2 more
-
Scottsdale, Arizona
- +13 more
May 10, 2022
Colorectal Cancer Trial in Philadelphia (R-1,3-Butanediol)
Recruiting
- Colorectal Cancer
- R-1,3-Butanediol
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 26, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +
Recruiting
- Advanced Solid Tumor
- +8 more
- PY314
- Combination Therapy: PY314 + Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Mar 28, 2022
Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,
Recruiting
- Metastatic Solid Tumor
- +6 more
- Surufatinib and Tislelizumab _ Part 1
- Surufatinib and Tislelizumab _ Part 2
-
Tucson, Arizona
- +17 more
Apr 1, 2022
Colorectal Cancer Trial in United States
Completed
- Colorectal Cancer
-
Duarte, California
- +45 more
Mar 29, 2022
Colorectal Cancer Trial in Puerto Rico, United States (Colonoscopy, FIT)
Active, not recruiting
- Colorectal Cancer
- Colonoscopy
- FIT
-
Phoenix, Arizona
- +45 more
Mar 1, 2022